Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Antioxidants for lung function?

This article was originally published in The Tan Sheet

Executive Summary

Results of a study "strongly suggest that beta-carotene protects against the decline in forced expiratory volume (FEV) over an eight-year period in the general population, and that beta-carotene and vitamin E are protective in heavy smokers," A. Guenegou, French National Health Institute INSERM, et al., state in the April issue of Thorax. The study followed 535 French subjects age 20-44 over eight years, 40% of whom were non-smokers. FEV was used as an endpoint since oxidative stress is thought to cause airway obstruction and thus lower FEV. An increase of beta-carotene was linked to slower FEV decline, though no association was found for alpha-carotene, vitamin A or vitamin E. Heavy smokers (> 20 cigarettes/day) with low levels of beta-carotene or vitamin E had the steepest FEV decline...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel